Lonza has acquired the rights to Nona Biosciences’ transferrin receptor [...]

Estonian biotechnology company Icosagen has completed a €45 million expansion [...]

Lonza will expand its highly potent active pharmaceutical ingredient manufacturing [...]

The European Commission has granted orphan drug designation to Chiesi [...]

Racura Oncology has treated the first patient in its Harness-1 [...]

Thalia Therapeutics has agreed a Sanmirna acquisition and £2.75m fundraise [...]

Meteor Biotech has joined a South Korean government-backed consortium aimed [...]

TRIMTECH Therapeutics has secured an additional $14 million in seed [...]

Atsena Therapeutics has dosed the first patient in the Phase [...]

Houdini Bio has launched a machine learning-guided DNA sequence design [...]